Atlas Trials

Ribociclib and Letrozole Treatment in Ovarian Cancer

Clinical trial NCT03673124 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03673124
Sponsor
Gynecologic Oncology Group
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Low Grade Serous Carcinoma
Start date
2019-05-20
Primary completion
2024-12-23
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.